🔗 Share this article

The prestigious award in medical science has been granted for revolutionary discoveries that illuminate how the body's defense network attacks harmful infections while sparing the body's own cells.

Three renowned scientists—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research identified unique "security guards" within the defense system that eliminate rogue defense cells capable of harming the organism.

The findings are now paving the way for new treatments for immune disorders and malignancies.

The laureates will share a monetary award worth 11 million Swedish kronor.

Decisive Findings

"Their work has been decisive for comprehending how the body's defenses operates and why we do not all develop severe autoimmune diseases," stated the chair of the Nobel Committee.

This team's studies explain a fundamental mystery: In what way does the immune system protect us from numerous infections while leaving our own tissues intact?

Our immune system uses white blood cells that scan for indicators of infection, even viruses and bacteria it has not met before.

These cells employ detectors—known as receptors—that are produced randomly in countless variations.

This provides the defense network the ability to fight a broad range of invaders, but the unpredictability of the process inevitably creates immune cells that can target the host.

Security Guards of the Body

Scientists previously understood that a portion of these problematic white blood cells were destroyed in the thymus—the site where immune cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to neutralize any immune cells that assault the healthy cells.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee added, "These discoveries have laid the foundation for a novel area of research and accelerated the creation of new therapies, for example for cancer and immune disorders."

Regarding malignancies, T-regs block the system from attacking the growth, so studies are aimed at reducing their quantity.

For self-attack disorders, trials are exploring boosting regulatory T-cells so the body is no longer being harmed. A similar method could also be useful in reducing the chances of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, of Osaka University, conducted tests on rodents that had their immune gland extracted, causing autoimmune disease.

He demonstrated that injecting immune cells from healthy mice could prevent the illness—suggesting there was a mechanism for blocking immune cells from harming the body.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in mice and people that resulted in the discovery of a genetic factor vital for how T-regs function.

"Their pioneering research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly targeting the healthy cells," said a prominent biological science specialist.

"This work is a remarkable example of how fundamental physiological research can have far-reaching implications for human health."